36 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... with Community-Acquired ... • Combination therapy ... fluoroquinolone #IDSA ... CAP #Community #Acquired
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... antifungals are required ... for effective treatment ... candida #mucosal #IDSA ... opportunistic #infections #HIVAIDS
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for induction therapy ... Meningoencephalitis #IDSA ... #Treatment #management ... #cryptococcus #HIVAIDS
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
Infections • Pulmonary ... count <50 • Pulmonary ... of starting OI treatment ... Antiretroviral #Therapy ... Infections #management #infectiousdiseases
IDSA Recommended therapy for patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens #Duration #IDSA
IDSA Recommended ... therapy for patients ... #Management #InfectiousDiseases ... #LymeDisease #Treatment ... Regimens #Duration #IDSA
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... areas Preferred Therapy ... Penicilliosis #IDSA ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... efficacy of this therapy ... Preferred Therapy ... Trypanosomiasis #IDSA ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... /ml Preferred Therapy ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... Tuberculosis - IDSA ... #pharmacology #IDSA ... #Guidelines #Treatment
Bacteremia Quick Reference - Treatment Duration

Gram Negative Bacteremia:
 • Avoid: Aminoglycosides and tigecycline
 • Catheters should
Quick Reference - Treatment ... follow up cultures required ... 14 days of IV therapy ... #Bacteremia #Treatment ... Management #Duration #infectiousdiseases